Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-01-27 @ 7:41 AM
Study NCT ID:
NCT02947061
Status:
UNKNOWN
Last Update Posted:
2016-10-31
First Post:
2016-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04
Start Date Type:
None
Primary Completion Date:
2017-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-04
Completion Date Type:
ESTIMATED
First Submit Date:
2016-10-25
First Submit QC Date:
None
Study First Post Date:
2016-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-27
Last Update Post Date:
2016-10-31
Last Update Post Date Type:
ESTIMATED